Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2022-08-10 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2022 半年度报告摘要' which translates to '2022 Semi-Annual Report Summary'. It contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for the half-year period. The document explicitly states it is a summary of the half-year report and references the full half-year report for more details. The presence of substantive financial data and analysis for a period shorter than a full fiscal year aligns with the definition of an Interim / Quarterly Report (IR). The document length is 3185 characters, which is relatively short but contains actual financial data, not just an announcement or a link to a report. Therefore, it is classified as an Interim / Quarterly Report (IR). H1 2022
2022-08-10 Chinese
北京诺禾致源科技股份有限公司股东集中竞价减持股份结果公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement from Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding the results of a concentrated bidding share reduction by a major shareholder. It details the shareholder's pre-reduction holdings, the planned reduction, the actual shares reduced, and the completion status of the reduction plan. The document does not contain financial statements or detailed financial analysis but focuses on the shareholder's shareholding changes and reduction results. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is short (2015 characters), and it is not an announcement of a report publication but a substantive announcement of shareholding changes. Therefore, the correct classification is MRQ with high confidence.
2022-08-08 Chinese
关于北京诺禾致源科技股份有限公司向特定对象发行股票申请文件的审核问询函
Capital/Financing Update Classification · 95% confidence The document is an official inquiry letter from the Shanghai Stock Exchange regarding a company's application for a specific share issuance to targeted investors. It discusses detailed questions about the company's fundraising project, financing scale, benefit forecasts, financial investments, operational conditions, and compliance. The document references regulatory frameworks and requests clarifications and confirmations from the company, its sponsors, and auditors. This type of document is typical of a regulatory review process for a capital raising or refinancing activity, specifically related to a share issuance application. It is not a full financial report, earnings release, or management discussion, but rather a regulatory inquiry related to a capital raising filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive regulatory inquiry letter.
2022-07-13 Chinese
北京诺禾致源科技股份有限公司关于2022年度向特定对象发行A股股票申请收到上海证券交易所审核问询函的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (691 characters) regarding the receipt of an inquiry letter from the Shanghai Stock Exchange about the company's application for a specific share issuance. It states the company will respond to the inquiry and disclose updates via temporary announcements. There is no detailed financial data, report content, or comprehensive analysis. The document is an update on a regulatory review process related to capital raising, not the actual issuance or detailed financing report. Therefore, it fits best under Capital/Financing Update (CAP).
2022-07-13 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司2022年度向特定对象发行股票之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to "Listing Sponsorship Letter" or "Sponsorship Document" related to a specific issuance of A shares by Beijing Novogene Co., Ltd. It contains detailed information about the company, its business, financial data, risk factors, issuance details, pricing, and the underwriting/sponsorship arrangements. The document is a formal filing related to a capital raising event through a directed share issuance to specific investors. It is not a general annual report, earnings release, or management discussion, but rather a detailed capital/financing update and issuance prospectus document. The presence of underwriting details, issuance pricing, subscription, and use of proceeds confirms this is a Capital/Financing Update filing. The document length is substantial and contains substantive financial and business information related to the issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-06-30 Chinese
立信会计师事务所（特殊普通合伙）关于北京诺禾致源科技股份有限公司2022年度向特定对象发行A股股票的财务报表及审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "审计报告及财务报表" which translates to "Audit Report and Financial Statements" for the fiscal year 2021. It includes detailed audit opinions, key audit matters, and extensive financial statements such as consolidated and parent company balance sheets, profit and loss statements, and cash flow statements. The presence of an auditor's opinion, detailed financial data, and notes indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length is substantial (15,000 characters), and it contains actual financial data and audit details, not just a certification or announcement. Therefore, it fits the category of Audit Report / Information (AR). FY 2021
2022-06-30 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.